News

ERC Proof of Concept project “PEPTIN” among finalists of Horizon Impact Award

Published on | 5 years ago

Programmes
ERC

Among the 10 finalists of the Horizon Impact Award 2020 is the ERC Proof of Concept project PEPTIN led by Principal Investigator Joost Schymkowitz and hosted at the VIB. PEPTIN was funded under the 2017 ERC Proof of Concept call and built further on the results of the ERC Consolidator project MANGO, that was funded under the 2014 call. PEPTIN, developed technology that revolutionizes antimicrobial treatment and provides an opportunity to rapidly identify molecules that are often resistant to antibiotics. The technology developed allows to target bacteria in a manner that has never been done before, preventing resistance to anti-bacterial treatment. To further exploit their biotechnology, the project consortia founded bio-incubator, a spin-off company to further commercialise the anti-bacterial drugs using the technology platform developed at an earlier stage.” The winners of the Horizon Impact Award will be announced at the award ceremony on 23 September at 9:45 (Brussels time) at the European Research and Innovation Days.

European Commission press release

Related news

Horizon Impact Award

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1851 articles available search in articles 

Testimonial

SAPHIRe - Securing the Adoption of Personalised Medicin in Regions

The Department of Economy, Science and Innovation of the Flemish government coordinates the Horizon 2020 Coordination and Support Action SAPHIRe, which started on 1 December 2018. The aim of the project is to secure the adoption of personalised medicine in all European regions, including sparsely populated and remote regions and regions with different innovation capacities. 

The activities of SAPHIRe are complementary to the smart specialisation partnership on personalised medicine – S3P4PM, which is also coordinated by the Department of Economy, Science and Innovation.